Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee

First Page		Document Content
Date: 2007-07-09 08:23:20 Satraplatin Johnson Matthey Chemistry GPC Biotech HRPC		Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 27,25 KB Share Document on Facebook